Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes 1-8 , but the low frequency and tendency to induce malignant transformation 9 compromise the clinical utility of this powerful approach. We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells. Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway. Reducing signalling to p53 by expressing a mutated version of one of its negative regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency. Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimaeric mice using only Oct4 (also known as Pou5f1) and Sox2. Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells. These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.
Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes [1] [2] [3] [4] [5] [6] [7] [8] , but the low frequency and tendency to induce malignant transformation 9 compromise the clinical utility of this powerful approach. We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells. Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway. Reducing signalling to p53 by expressing a mutated version of one of its negative regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency. Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimaeric mice using only Oct4 (also known as Pou5f1) and Sox2. Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells. These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.
The p53 pathway reduces cancer initiation by inducing apoptosis or cell cycle arrest in response to a variety of stress signals, including overexpressed oncogenes such as c-Myc. Klf4 can either activate or antagonize p53, depending on the cell type used and expression level 10 . Consequently, reprogramming efficiency is probably reduced through oncogene-mediated activation of the p53 pathway. This is consistent with previous results showing that germ cells can be spontaneously reprogrammed in the absence of p53 (ref. 11) , and a combination of p53 short interfering RNA (shRNA) and Utf1 expression increased iPS cell formation 12. We first determined whether the reprogramming factors, individually or in combination, activate the p53 pathway in mouse embryo fibroblasts (MEFs). Relative to the green fluorescent protein (GFP)retroviral control, c-Myc considerably increased p53 abundance and activity, manifested by increased expression of the cyclin-dependent kinase inhibitor p21 ( Fig. 1a ). This was achieved by induction of p19 Arf , an antagonist of Mdm2, the E3-ubiquitin ligase principally responsible for p53 degradation 13 . Increased p21 protein levels were also observed in MEFs infected with Klf4 alone, with Oct4 and Sox2 (two factors) or with Oct, Sox2 and Klf4 (three factors) ( Fig. 1a ). Because introducing reprogramming factors increased c-H2ax (also known as c-H2afx) foci ( Supplementary Fig. 1 ), we infer that the expression of reprogramming factors may induce p53 activity by DNA damage. We also compared p53 and p21 expression in a variety of mouse and human cell lines previously used for iPS cell production ( Supplementary Fig. 2 ). Interestingly, keratinocytes, which have higher reprogramming efficiency, display lower p53 and p21 protein levels than other cell types. Moreover, p21 induction in keratinocytes is lower than in fibroblasts after infection with the three factors ( Supplementary Fig. 3 ). Together, these data indicate that the p53 pathway is one determinant of reprogramming efficiency.
We therefore tested the effects of reducing p53 signalling by determining reprogramming efficiencies in cells in which p53 function was reduced by shRNA or ablated by homologous recombination. Most cells were infected with shRNA ( Supplementary Fig. 4 ), p53 messenger RNA and protein levels were reduced by 60-80% ( Fig. 1c and Supplementary Fig. 5 ), and iPS cell colony formation was increased by 2-4-fold using two different shRNAs (Fig. 1b, c ). This probably underestimates p53 suppressive capacity, because functional p53 protein clearly remained present, as indicated by the ability of the p53 activating agent Nutlin-3a (ref. 14) to dose-dependently reduce iPS cell formation in MEFs treated with the most effective p53 shRNA ( Fig. 1d ). In contrast, reprogramming efficiency was increased by at least tenfold in p53-null MEFs, and this was not reduced by Nutlin-3a (Supplementary Table 1 and Fig. 1e , g). p53 1/2 heterozygous MEFs also exhibited higher three-factor-reprogramming efficiency than wild-type MEFs. Although culture stress can induce cellular senescence and activate p53, which would reduce reprogramming, less than 1% of the cells of all p53 genotypes stained with the senescence marker b-galactosidase ( Supplementary Fig. 6 ). Because we did not detect loss of heterozygosity of the p53 gene in iPS cell colonies derived from p53 1/2 MEFs ( Supplementary Fig. 7) , the data suggest a p53 dosage-sensitivity to reprogramming ( Fig. 1e ). We were concerned that because p53-null MEFs are genetically unstable, increased reprogramming efficiency might result from expression of the three factors in variant cells. However, we found that re-expressing p53 protein in the p53-null MEFs markedly reduced reprogramming efficiency ( Fig. 1f ).
Reducing factors downstream of p53 also increased reprogramming efficiency. For example, p21 shRNA increased reprogramming by approximately threefold (Fig. 1h ). This probably underestimates the magnitude to which p21 induction suppresses reprogramming as p21-shRNA-expressing cells still responded to Nutlin-3a treatment as discussed earlier. We also noted a modest induction of the proapoptotic factor Bax, another p53-inducible gene 15 , in three-factor experiments (data not shown). Consistent with a limiting role of the p53-induced apoptotic response during reprogramming, overexpression of the Bax antagonist Bcl2 suppressed apoptosis in two, three and four factor experiments, and increased the frequency of colonies expressing the pluripotency factor Nanog by fourfold ( Supplementary Fig. 8 ). The three-factor-transduced colonies exhibit the characteristics of iPS cells, with mouse embryonic stem (ES) cell morphology, high levels of alkaline phosphatase activity and expression of pluripotency-associated transcription factors and surface markers, and ability to differentiate into derivatives of all three embryonic germ layers in vitro ( Supplementary Figs 9-11 ). Taken together with the genetic and shRNA studies described earlier, these data show that complete loss of p53 function markedly increases reprogramming efficiency, and that even low levels of p53 activity are all that is needed to compromise somatic cell reprogramming.
The ability of the three factors to increase p53 abundance suggests that controlling its stability might be crucial for p53-mediated reprogramming suppression. Thus we determined whether reducing p19 Arf levels using Arf shRNA increases reprogramming efficiency, as lower Arf levels should decrease p53 stability [16] [17] [18] . Reducing p19 Arf levels by 2-4-fold ( Fig. 2a ) engendered an approximately twofold increase in three-factor-reprogramming ( Fig. 2a ). Reducing p19 Arf and p16 Ink4a (both encoded by alternative reading frames of the Ink4a/Arf locus, also known as Cdkn2a locus) together increased iPS cell formation even more than p19 Arf alone (4-5-fold; Fig. 2b ), indicating that compromising retinoblastoma (Rb) tumour suppressor 19 function by antagonizing p16 Ink4a can collaborate with diminished p53 activity to improve reprogramming efficiency. a, MEFs were infected by retroviruses encoding three factors (Oct4, Sox2 and Klf4), two factors (Oct4 and Sox2), Klf4, c-Myc or GFP. Four days after infection, the protein levels of p53, p19 Arf and p21 were analysed by western blotting. a-tubulin was used as a loading control. b, MEFs were infected by three factors in combination with mock, control (Ctrl) shRNA (GFP) and p53 shRNA (1 and 2). Emerging colonies of iPS cells were visualized by immunostaining with an anti-Nanog antibody using an avidin-biotin complex method. c, The fold-change in the number of Nanog-positive colonies compared to mock (n 5 4) (top). p53-knockdown efficiency was examined by western blot (bottom). d, MEFs were infected by three factors in combination with mock, p53 shRNA and p21 shRNA. Four days later, half the cells were treated with Nutlin-3a (0, 3 and 10 mM) and analysed for p53 levels. The remainder were stained for Nanog-positive colonies. e, Immunostaining of Nanog-positive colonies generated from p53 1/1 , p53 1/2 and p53 2/2 MEFs by three-factors showed p53 dose-dependent decrease of colony number. f, Retroviral infection of p53 into p53 2/2 MEFs decreased the number of Nanog-positive colonies induced by three factors. p53 and p21 levels on day 3 after infection were analysed. g, Nutlin-3a markedly reduced reprogramming of p53 1/1 MEFs, but not of p53 
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We next genetically modulated the activity of the E3 ligase that regulates p53 stability by generating a mouse encoding a mutant version of Mdmx (also known as Mdm4), a critical negative regulator of p53. We substituted three serine residues with alanines (Mdmx Ser 341, Ser 367 and Ser 402, hereafter called Mdmx3SA) to prevent its phosphorylation and degradation in response to DNA damage or activated oncogenes 20, 21 . Notably, MEFs or thymocytes derived from homozygous Mdmx3SA mice exhibited lower basal expression of p21, lower DNA damage induced p21 levels ( Supplementary Fig. 12 and ref. 21) and an impaired ability of c-Myc to activate p53 in vivo 21 . Three-factor-reprogramming increased ,7-fold in Mdmx3SA MEFs, in agreement with their reduced sensitivity to activated oncogenes and DNA damage signalling (Fig. 2c) .
Because Klf4 has been reported to have oncogenic properties when overexpressed 22 , and we showed that it alone can activate p53, we investigated whether cells with reduced p53 expression could be converted into iPS cells using only two factors, Oct4 and Sox2. We tested this hypothesis by transducing MEFs with a lentivirus expressing p53 shRNA plus retroviruses encoding Oct4 and Sox2 (hereafter designated as 2F-p53KD-iPS cells; Supplementary Fig. 13 ). Cells that developed into colonies exhibiting ES-cell-like morphology were obtained by week 4 after infection. Of six colonies selected for analysis, four grew using standard mouse ES cell culturing methods (Fig. 3a) , and all were alkaline-phosphatase-positive ( Fig. 3b) and expressed genes and cell surface markers characteristic of mouse ES cells, including the pluripotency marker Nanog ( Fig. 3c and Supplementary Fig. 14) .
2F-p53KD-iPS cells and mouse ES cell lines had indistinguishable gene expression patterns when maintained under similar conditions.
Bisulphite sequencing of the Oct4 and Nanog promoters showed nearly complete demethylation in 2F-p53KD-iPS cells when compared to MEFs ( Supplementary Fig. 14) . Consistent with this, we observed expression of the pluripotency-associated transcription factors Oct4 and Sox2 from the endogenous loci in 2F-p53KD-iPS cells, at levels that were comparable to those of ES cells ( Supplementary Fig. 15 ).
Also, like ES cells, most (70-80%) cells were in S-phase (Supplementary Fig. 16 ). We tested the pluripotency of three 2F-p53KD-iPS clones in assays of embryoid body formation in vitro and/or teratoma induction in vivo. The tested cell lines differentiated into the three germ layer derivatives, as shown by immunostaining and mRNA expression in vitro ( Fig. 3d and Supplementary Fig. 17 ). Furthermore, these cells differentiated with high efficiency into beating cardiomyocytes (Supplementary Fig. 18 and Supplementary Movies 1-3 ). After injection into immunocompromised mice, two independent 2F-p53KD-iPS lines generated complex intratesticular and subcutaneous teratomas containing structures and tissues representative of the three embryonic germ layers (Fig. 3e ). Microarray analyses demonstrate that gene expression patterns of these clones are similar to mouse ES cells ( Supplementary Fig. 19 ). We also tested whether 2F-p53KD-iPS cells contribute to the formation of chimaeric mice when injected into mouse blastocysts. One line (clone 6) contributed almost 100% to chimaera formation, and the other line (clone 1) contributed 30-50%, as judged by coat colour (Fig. 3f and Supplementary Fig. 20) . We finally used the highest contribution chimaera to test for germline competence by crossing it with wild-type C57BL/6J mice. Notably, the offspring of such crosses included agouti pups (Fig. 3g) , indicating germline transmission of the two-factor-iPS genome. Taken together, these results demonstrate that MEFs can be reprogrammed to pluripotency by the forced expression of only two factors, Oct4 and Sox2, when p53 levels are reduced.
We next tested whether downregulating p53 activity had any effect on the reprogramming of human embryonic fibroblasts (HEFs) and juvenile epidermal keratinocytes. We could not obtain Nanog-positive colonies from HEFs with either three or four factors combined with control shRNA under our reprogramming conditions after up to 4 weeks. In contrast, cell reprogramming occurred rapidly (after 2 weeks) with high efficiency when p53 expression was reduced by shRNA ( Fig. 4a and Supplementary Figs 22, 23 and Supplementary  Table 2 ). p53 shRNA induced ES-cell-like colonies, expressed human Embryoid bodies were transferred to gelatinized dishes on days 3 to 5 for further differentiation. On day 14, embryoid bodies were subjected to immunofluorescence for a-fetoprotein (AFP) and Foxa2 (endoderm), a-sarcomeric actin and Gata4 (mesoderm) and Tuj1 and GFAP (ectoderm). e, Immunofluorescence of teratoma from 2F-p53KD-iPS cells using antibodies against AFP and Foxa2 (endoderm), sarcomeric a-actinin and chondroitin (mesoderm), and Tuj1 and GFAP (ectoderm) showed spontaneous differentiation into all three germ layers. Original magnification (d, e), 3400. f, Adult chimaeric mice obtained from 2F-p53KD-iPS cell lines (1 and 6) and non-chimaeric mouse in C57BL/6J host blastocysts. g, As of the date of submission, the mating of offspring from clone 6 chimaera to a C57BL/6J female generated 1 agouti pup (blue arrow), that together with PCR analysis (not shown) indicate germline transmission of the two-factor iPS genome.
ES cell marker genes, could be successfully cloned and expanded, exhibited ES-cell-like morphology, and differentiated in vitro in embryoid body formation assays ( Supplementary Figs 24 and 25 ). We also obtained two-factor-induced iPS cell colonies from HEFs infected with p53 shRNA, although with lower efficiency (two iPS cell colonies resulted from six independent attempts, Supplementary Fig. 26 ). Consistently, reprogramming efficiency was increased using either three or four factors in human primary keratinocytes when p53 activity was downregulated using a dominant negative mutant of p53 (p53DD) 23 (Fig. 4b, c ) that inhibited p53 activity more effectively than p53 shRNA, because Nutlin-3a did not reduce reprogramming of three-factor or four-factor p53DD expressing iPS cells (Fig. 4c ). 3F-p53DD-iPS cells grew robustly and strongly expressed pluripotency-associated transcription factors and surface markers ( Fig. 4d and data not shown) . Furthermore, 3F-p53DD-iPS cells readily differentiated in vitro into derivatives of the three embryonic germ layers as judged by cell morphology and specific immunostaining (Fig. 4e) . These results show that p53 activity limits reprogramming of both mouse and human cells.
Oct4, Sox2 and Nanog interact with each other to enable the genomewide chromatin remodelling required for induction of pluripotency. None of these factors are expressed at detectable levels in somatic cells. Previous work showed that p53 represses Nanog in response to DNA damage in ES cells 24 , raising the possibility that p53 might prevent Nanog expression in MEFs. However, we observed that Nanog mRNA was not expressed at detectable levels in either p53 wild-type or p53-null MEFs ( Supplementary Fig. 11a and data not shown). On the other hand, the oncogene Klf4 has been reported to induce Nanog 25 . It is possible that in the absence of Klf4 in two-factor iPS cells, p53 elimination allowed Oct4 and Sox2 to remodel the chromatin to a threshold required for expression of sufficient Nanog to drive the subsequent events involved in iPS cell generation.
Our data show that reprogramming somatic cells to iPS cells is associated with activation of the p53 pathway, which acts as a barrier to reprogramming. The mechanisms by which p53 antagonizes reprogramming seem to involve both its ability to limit cell cycling by induction of the cyclin-dependent kinase inhibitor p21 and its ability to induce apoptosis. This suggests that direct chemical inhibition of the apoptotic cascade may provide a useful tool for enhancing reprogramming efficiency without direct genetic manipulation of tumour suppressors. We also show that reprogramming in the absence of oncogenes such as c-Myc and Klf4 will require inactivating the p53 and Rb tumour suppressors. Although p53 pathway inactivation will be key, this cannot be done on a permanent basis, as this would increase the probability of malignant transformation and the generation of unstable genomes that would mitigate their use for understanding many diseases. Rather, transient inhibition using chemical antagonists or reversible approaches that avoid genetic disruption will be required 12, 26 . As Oct4 and Sox2 are oncogenic when overexpressed, using small molecules or proteins to transiently mimic their reprogramming functions [27] [28] [29] may enable oncogene-free iPS cells to be obtained at acceptable frequencies. The mechanistic insights we provide ( Supplementary Fig. 27 ) should shorten the road to developing clinically useful iPS cells.
METHODS SUMMARY
MEFs were isolated from embryonic day (E) 13.5 embryos obtained from wildtype, p53-deficient, or Mdmx-mutant mice. Retroviral and lentiviral viruses were produced in HEK293 cells, and 12 to 14 days after infection MEFs were fixed for immunofluorescence. Reprogramming of HEFs (IMR90) and keratinocytes was done as previously described 2,3,6 . Around two to three weeks after infection, cells were fixed for immunofluorescence studies. As for two-factor iPS cell formation, after a minimum of 4 weeks, colonies derived from infected MEFs or IMR90 cells were fixed for immunostaining or picked up for clonal expansion. Protein, mRNA, promoter methylation, microarray and immunofluorescence analyses were performed by standard methods 30 . In vitro differentiation of mouse iPS cells was established by the hanging-drop method, whereas human iPS cells were differentiated by suspension culture. Teratomas were induced by shRNA. Emerging colonies of iPS cells were immunostained with anti-Nanog antibody (top). p53-knockdown efficiency was examined by western blot (bottom). b, Human primary keratinocytes were co-infected with four factors and retroviruses expressing GFP or p53DD. After 2 weeks, cells were stained for alkaline phosphatase activity (top). Expression of p53DD resulted in stabilization of wild-type p53 (bottom). Actin was used as a loading control. c, The average number of iPS-cell-like colonies obtained from 10 4 keratinocytes reprogrammed with three or four factors and retroviruses encoding GFP or p53DD, in the absence or presence of Nutlin-3a (n 5 3). iPS-cell-like colonies were scored as having human ES-cell-like morphology and positive alkaline phosphatase staining. Owing to the numerous colonies generated in four-factor p53DD keratinocytes, quantification was done using 10 4 cells. Error bars, s.d. d, e, Colonies of human keratinocyte-derived iPS cells generated by three factors and p53DD show strong immunoreactivity for pluripotency-associated transcription factors (Oct4, Sox2, and Nanog) and surface markers (TRA-1-60 and TRA-1-81) (d) and differentiate in vitro into cell types that express markers of endoderm (a-fetoprotein, Foxa2), mesoderm (Gata4, sarcomeric a-actinin), and ectoderm (Tuj1, tyrosine hydroxylase (TH)) (e).
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LETTERS injecting iPS cells subcutaneously and into the testicles, and analysed three to four weeks after injection. Chimaeric mice were obtained by injecting iPS cells into C57BL/6J hosts. High-contribution chimaeras were mated to C57BL/6J mice to test for germline transmission.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
